Myasthenia gravis (MG) results from autoimmune antibodies against the post-synaptic neuromuscular junction with three major ...

Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte ...

Medications prescribed to boost acetylcholine and suppress ... challenge previous assumptions about how myasthenia gravis antibodies disrupt receptor activity. By mapping antibody binding sites ...

your body attacks its acetylcholine receptors. Myasthenia gravis is considered to be an autoimmune disorder. In an autoimmune disease, some of the body's antibodies (special proteins in your body ...

Autoimmune generalized myasthenia gravis is a disease that manifests with fluctuating muscle weakness. Inebilizumab is a monoclonal antibody that depletes CD19+ B cells, which are central to ...

gMG is different from ocular myasthenia gravis, which only affects the eye muscles. “Anti-acetylcholine receptor (AChR) antibody-positive” means your immune system makes antibodies that block ...

in adults living with generalized myasthenia gravis (gMG). The results demonstrated durable and sustained efficacy of UPLIZNA in patients with acetylcholine receptor autoantibody-positive (AChR+ ...

"All three types of myasthenia gravis ... ryanodine receptor, collagen Q, and cortactin -- have been suggested as potential binding sites for antibodies that cause weakness.

Morningstar brands and products Company Portfolio ...